Trials / Conditions / Idiopathic Pulmonary Arterial Hypertension

Idiopathic Pulmonary Arterial Hypertension

23 registered clinical trials studyying Idiopathic Pulmonary Arterial Hypertension — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH) NCT06104228	Bastiaan Driehuys	Phase 2
Active Not Recruiting	Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Mo NCT06587074	Russian Cardiology Research and Production Center	—
Completed	Empagliflozin in Pulmonary Arterial Hypertension NCT05493371	Amsterdam UMC, location VUmc	Phase 2
Recruiting	Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH) NCT05462574	Vanderbilt University Medical Center	—
Recruiting	Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals NCT05584722	Vanderbilt University Medical Center	—
Completed	StratosPHere (Non-interventional Study) NCT05767918	Papworth Hospital NHS Foundation Trust	—
Unknown	The PAH Platform for Deep Phenotyping in Korean Subjects NCT03933579	Gachon University Gil Medical Center	—
Completed	A Mobile Health Intervention in Pulmonary Arterial Hypertension NCT03069716	Vanderbilt University Medical Center	N/A
Completed	Acute Effects of Benzbromaron on the Pulmonary Circulation NCT02790450	Medical University of Graz	Phase 2
Completed	Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome NCT02565030	Sheffield Teaching Hospitals NHS Foundation Trust	—
Unknown	Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies NCT02959723	Universitaire Ziekenhuizen KU Leuven	—
Withdrawn	Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension NCT02108743	American Medical Association Foundation	Phase 2
Recruiting	Hormonal, Metabolic, and Signaling Interactions in PAH NCT01884051	Vanderbilt University Medical Center	—
Unknown	Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline Malate NCT01683981	Masih Daneshvari Hospital	EARLY_Phase 1
Withdrawn	Efficacy Study of Cardizem in Pulmonary Arterial Hypertension NCT01645826	University of South Florida	N/A
Completed	Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension NCT01613287	Miltenyi Biotec B.V. & Co. KG	N/A
Completed	The Study of Apelin-APJ System on Pulmonary Hypertension Patients and Healthy Subjects NCT01590108	Imperial College London	Phase 1
Unknown	Beta-blockers in i-PAH NCT01246037	Amsterdam UMC, location VUmc	Phase 1 / Phase 2
Unknown	Iron Deficiency In Pulmonary Hypertension NCT01288651	Amsterdam UMC, location VUmc	Phase 4
Unknown	Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension NCT00372346	Zhejiang University	N/A
Completed	Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic NCT00641836	Zhejiang University	N/A
Completed	Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Te NCT00626028	Mallinckrodt	Phase 3
Completed	Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension NCT00257413	Zhejiang University	N/A